Boundless Bio, Inc. (BOLD) › Cash & EquivalentsBoundless Bio, Inc. (BOLD) — Cash & EquivalentsAnnual figures by fiscal year, from SEC filings.2023: $23.71M2024: $26.59M2025: $17.87M$17.87M2023Cash & Equivalents (USD)2025Fiscal YearCash & EquivalentsChange YoY2025$17.87M-32.8%2024$26.59M+12.2%2023$23.71M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share